More Information
Lymphoma Information Network » Lymphoma Info » Angioimmunoblastic T-Cell Lymphoma

Angioimmunoblastic T-Cell Lymphoma

lymphadenopathy
Ultrasound throat - lymphadenopathy

Angioimmunoblastic T-cell Lymphoma (AILT), aka immunoblastic lymphadenopathy, is an aggressive cancer that originates in the T-cells. It accounts for 1% of all Non-Hodgkin’s Lymphomas (NHL) and is found mostly in the elderly. Males have a higher incidence than females.

"Angio" is a term that refers to the blood vessels. This cancer is marked by the presence of abnormal blood vessels in affected body parts. AILT typically affects the lymph nodes, skin, liver, spleen, and bone marrow.

Immunoblasts are immature immune cells. AILT originates in immature T-cells that circulate in the blood.

Diagnosis and Staging

Most patients present with typical lymphoma symptoms, such as fever, night sweats, chills, swollen lymph nodes, and weight loss. Some patients will also have a skin rash. In the later stages, patients may be anemic (low red blood cell and/or hemoglobin count) or have other blood abnormalities, so they’ll experience fatigue as a result.

Sponsored Links

A lymph node biopsy is used to diagnose the disease, and other follow-up tests like CT scans, PET scans, X-rays, and bone marrow biopsies are done to stage the cancer. Due to the rarity of this disease, concrete staging information is not available.

Treatment

Treament usually begins with steroids to help with inflammation and rashes. After steroid treatment, the CHOP regimen of chemotherapy is usually administered.

In cases of relapse, bone marrow transplants are usually tried.

More Information

Get Free Health Insurance Quotes

Zip Code:

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Cancer Support Groups

SupportGroups.com builds awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Clinical Trials

Cancer Patients have more options through clinical studies. Follow this link to learn more and find a clinical study opportunity near you.

Dive Deeper

Resources

Non-Hodgkin's Lymphoma Information Pages:

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

More Information
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Latest Blog Entries
User login
Poll
What is most important to you in an Online Support Group?:
Did You Know?

Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Improved diagnosis has contributed greatly to the increase as doctors better understand cancer of lymphocytes and can distinguish it from other diseases.

lymphomas